Literature DB >> 7059451

Relation of growth delay to cure for experimental tumour systems conforming to Poisson cure statistics.

T E Wheldon, G F Brunton.   

Abstract

In tumour regrowth-delay experiments, the analysis of results in the higher dose ranges may be complicated by a dose-dependent proportion of non-recurrent (cured) tumours, whose inclusion in the analysis is not straightforward. A study of the relation of growth delay to cure has been carried out using a model of tumour response which assumes Poisson (single-cell) cure statistics and exponential regrowth kinetics of recurrent tumours, and which makes use of Monte Carlo simulation techniques to represent the effects of inter-tumour heterogeneity. This approach yields correction factors compensating for tumour cures in growth-delay experiments. For homogeneous tumour systems (all tumours and treatments identical) these corrections are small and not significantly different from corrections obtained using the "long delay" procedure suggested previously (Denekamp, 1980; Fowler et al., 1980). For heterogeneous systems, however, correction factors increase with the heterogeneity of the system, and may become quite large. It is concluded that the quantitative assessment of heterogeneity is required, and a possible approach to this is suggested. Should evaluation of heterogeneity prove feasible, it will allow more efficient use of tumour-response data, and may permit realistic estimates of clonogenic cell survival in situ.

Entities:  

Mesh:

Year:  1982        PMID: 7059451      PMCID: PMC2010945          DOI: 10.1038/bjc.1982.1

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  4 in total

1.  Letter: Tumour growth delay and cell survival "in situ".

Authors:  N J McNally
Journal:  Br J Radiol       Date:  1974-08       Impact factor: 3.039

2.  Letter: Comparison of tumour growth delay with cell survival.

Authors:  J M Brown; A E Howes
Journal:  Br J Radiol       Date:  1974-08       Impact factor: 3.039

3.  Hypoxic cell sensitization by misonidazole in vivo and in vitro.

Authors:  N J McNally; J Denekamp; P W Sheldon; I R Flockhart
Journal:  Br J Radiol       Date:  1978-04       Impact factor: 3.039

4.  Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

Authors:  T C Stephens; J H Peacock
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

  4 in total
  2 in total

1.  Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.

Authors:  R Osieka; P Glatte; R Pannenbäcker; C G Schmidt
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

2.  131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

Authors:  M N Gaze; R J Mairs; S M Boyack; T E Wheldon; A Barrett
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.